[Skip to Content]
[Skip to Content Landing]
Views 2,887
Citations 0
Research Letter
August 13, 2019

Pulmonary Embolism Hospitalization, Readmission, and Mortality Rates in US Older Adults, 1999-2015

Author Affiliations
  • 1Division of Cardiology, Columbia University Medical Center, New York, New York
  • 2Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, Connecticut
  • 3Respiratory Department, Hospital Ramón y Cajal, Madrid, Spain
  • 4Hospital Universitari Germans Trias i Pujol, Badalona, Spain
  • 5Division of Cardiovascular Medicine, Brigham and Women’s Hospital, Boston, Massachusetts
JAMA. 2019;322(6):574-576. doi:10.1001/jama.2019.8594

Over the past 15 years, advances have occurred in the diagnosis and management of pulmonary embolism (PE).1 Computed tomographic pulmonary angiography (CTPA) is now the routine diagnostic test. The availability of risk stratification tools and non–vitamin K antagonist oral anticoagulants that do not require routine laboratory monitoring have facilitated early discharge of patients.2